Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Tumor penetration of Sub-10 nm nanoparticles: effect of dendrimer properties on their penetration in multicellular tumor spheroids.

Bugno J, Poellmann MJ, Sokolowski K, Hsu HJ, Kim DH, Hong S.

Nanomedicine. 2019 Oct;21:102059. doi: 10.1016/j.nano.2019.102059. Epub 2019 Jul 13.

PMID:
31310808
2.

Tongue-out versus tongue-in position during intensity-modulated radiotherapy for base of tongue cancer: Clinical implications for minimizing post-radiotherapy swallowing dysfunction.

Kil WJ, Kulasekere C, Hatch C, Bugno J, Derrwaldt R.

Head Neck. 2017 Aug;39(8):E85-E91. doi: 10.1002/hed.24809. Epub 2017 May 5.

PMID:
28475284
3.

Chemical Structure and Surface Modification of Dendritic Nanomaterials Tailored for Therapeutic and Diagnostic Applications.

Myung JH, Hsu HJ, Bugno J, Tam KA, Hong S.

Curr Top Med Chem. 2017;17(13):1542-1554. doi: 10.2174/1568026616666161222104112. Review.

PMID:
28017148
5.

Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.

Jiang X, Bugno J, Hu C, Yang Y, Herold T, Qi J, Chen P, Gurbuxani S, Arnovitz S, Strong J, Ferchen K, Ulrich B, Weng H, Wang Y, Huang H, Li S, Neilly MB, Larson RA, Le Beau MM, Bohlander SK, Jin J, Li Z, Bradner JE, Hong S, Chen J.

Cancer Res. 2016 Aug 1;76(15):4470-80. doi: 10.1158/0008-5472.CAN-15-2949. Epub 2016 Jun 8.

6.

Dendrimer-based nanocarriers: a versatile platform for drug delivery.

Hsu HJ, Bugno J, Lee SR, Hong S.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1). doi: 10.1002/wnan.1409. Epub 2016 Apr 29. Review.

PMID:
27126551
7.

miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.

Jiang X, Hu C, Arnovitz S, Bugno J, Yu M, Zuo Z, Chen P, Huang H, Ulrich B, Gurbuxani S, Weng H, Strong J, Wang Y, Li Y, Salat J, Li S, Elkahloun AG, Yang Y, Neilly MB, Larson RA, Le Beau MM, Herold T, Bohlander SK, Liu PP, Zhang J, Li Z, He C, Jin J, Hong S, Chen J.

Nat Commun. 2016 Apr 26;7:11452. doi: 10.1038/ncomms11452.

8.

Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.

Bugno J, Hsu HJ, Pearson RM, Noh H, Hong S.

Mol Pharm. 2016 Jul 5;13(7):2155-63. doi: 10.1021/acs.molpharmaceut.5b00946. Epub 2016 Feb 10.

PMID:
26828309
9.

Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.

Bugno J, Hsu HJ, Hong S.

J Drug Target. 2015;23(7-8):642-50. doi: 10.3109/1061186X.2015.1052077. Review.

10.

Recent advances in targeted drug delivery approaches using dendritic polymers.

Bugno J, Hsu HJ, Hong S.

Biomater Sci. 2015 Jul;3(7):1025-34. doi: 10.1039/c4bm00351a. Epub 2014 Dec 11.

11.

Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles.

Sunoqrot S, Bugno J, Lantvit D, Burdette JE, Hong S.

J Control Release. 2014 Oct 10;191:115-22. doi: 10.1016/j.jconrel.2014.05.006. Epub 2014 May 14.

12.

Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.

Modi DA, Sunoqrot S, Bugno J, Lantvit DD, Hong S, Burdette JE.

Nanoscale. 2014 Mar 7;6(5):2812-20. doi: 10.1039/c3nr05042d. Epub 2014 Jan 27.

PMID:
24468839

Supplemental Content

Support Center